Literature DB >> 3378684

Epidemiology of persistent proteinuria in type II diabetes mellitus. Population-based study in Rochester, Minnesota.

D J Ballard1, L L Humphrey, L J Melton, P P Frohnert, P C Chu, W M O'Fallon, P J Palumbo.   

Abstract

Clinical risk factors for nephropathy were assessed in a population-based study of Rochester, Minnesota, residents with diabetes mellitus initially diagnosed between 1945 and 1969 (incidence cohort). The 1031 Rochester residents with non-insulin-dependent diabetes mellitus (NIDDM) were followed through their complete medical records in the community to 1 January 1982. The prevalence of persistent proteinuria was 8.2% at the diagnosis of NIDDM. Among those initially free of persistent proteinuria, the subsequent incidence was 15.3/1000 person-yr. Twenty years after the diagnosis of diabetes, the cumulative incidence of persistent proteinuria was 24.6%. A proportional hazards model identified the following risk factors for persistent proteinuria in NIDDM: elevated initial fasting blood glucose (P less than .01); older age at onset of diabetes (P less than .01); male gender (P = .05); and presence of macrovascular disease (P = .05), diabetic retinopathy (P = .05), or glycosuria (P = .07) at the diagnosis of diabetes. Separate analyses controlling for attained age indicated no association between duration of NIDDM and the incidence of persistent proteinuria. Stratified analysis of the two most significant risk factors (fasting blood glucose and age) indicated that hyperglycemia was a stronger risk factor for proteinuria in younger diabetic subjects, perhaps because of a competing risk of death in the elderly diabetic patient. In contrast to a recently described decreasing secular trend of proteinuria in Danish insulin-dependent diabetes mellitus patients, there was no decrease over the past 40 yr in proteinuria risk in this NIDDM incidence cohort.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3378684     DOI: 10.2337/diab.37.4.405

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  52 in total

Review 1.  Management of diabetic nephropathy.

Authors:  L Foggensteiner; S Mulroy; J Firth
Journal:  J R Soc Med       Date:  2001-05       Impact factor: 5.344

Review 2.  Diabetic nephropathy: worldwide epidemic and effects of current treatment on natural history.

Authors:  Peter Rossing
Journal:  Curr Diab Rep       Date:  2006-12       Impact factor: 4.810

Review 3.  Mechanisms of diabetic renal and cardiovascular disease.

Authors:  G C Viberti
Journal:  Acta Diabetol Lat       Date:  1990 Jul-Sep

4.  Prediction, progression and prevention of diabetic nephropathy. The Minkowski Lecture 2005.

Authors:  P Rossing
Journal:  Diabetologia       Date:  2005-12-09       Impact factor: 10.122

5.  Association between a polymorphism in the angiotensin-converting enzyme gene and microvascular complications in Japanese patients with NIDDM.

Authors:  Y Doi; H Yoshizumi; M Yoshinari; K Iino; M Yamamoto; K Ichikawa; M Iwase; M Fujishima
Journal:  Diabetologia       Date:  1996-01       Impact factor: 10.122

Review 6.  The relationship between glucose control and the development and progression of diabetic nephropathy.

Authors:  Carrie A Phillips; Mark E Molitch
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

7.  Danish general practitioners' estimation of urinary albumin concentration in the detection of proteinuria and microalbuminuria.

Authors:  N D Olivarius; C E Mogensen
Journal:  Br J Gen Pract       Date:  1995-02       Impact factor: 5.386

Review 8.  Evaluation and approach to treatment of renal artery stenosis in patients with diabetic nephropathy.

Authors:  Jose A Silva
Journal:  Curr Diab Rep       Date:  2008-12       Impact factor: 4.810

Review 9.  Diabetic nephropathy.

Authors:  Michael Shlipak
Journal:  BMJ Clin Evid       Date:  2009-01-14

10.  Effects of aggressive approach to the multiple risk factors for diabetic nephro-pathy on proteinuria reduction in diabetes type 2 patients.

Authors:  Belma Ascić-Buturović; Mirsad Kacila; Mehmed Kulić
Journal:  Bosn J Basic Med Sci       Date:  2009-02       Impact factor: 3.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.